【结 构 式】 |
【分子编号】63304 【品名】[5-[(3,5-dichlorophenyl)sulfanyl]-4-isopropyl-1-(4-pyridinylmethyl)-1H-imidazol-2-yl]methyl acetate 【CA登记号】 |
【 分 子 式 】C21H21Cl2N3O2S 【 分 子 量 】450.38816 【元素组成】C 56% H 4.7% Cl 15.74% N 9.33% O 7.1% S 7.12% |
与该中间体有关的原料药合成路线共 1 条
合成路线1
该中间体在本合成路线中的序号:(XXI)Esterification of 4-isopropyl-1-(4-pyridylmethyl)-1H-imidazol-2-ylmethanol (XVIII) by means of acetyl chloride and triethylamine in dichloromethane gives the acetate ester (XX), which is condensed with 3,5-dichlorophenylsulfanyl chloride (XVII) by means of triethylamine in toluene/acetonitrile to yield the thioether (XXI). Hydrolysis of the acetate group of compound (XXI) by means of NaOH in ethanol affords the hydroxymethyl compound (XII), which is finally condensed with chlorosulfonyl isocyanate in acetonitrile.
【1】 Sorbera, L.A.; Castañer, J.; Bayes, M.; Capravirine. Drugs Fut 2003, 28, 12, 1149. |
【2】 Kabaki, M.; Hajima, M.; Hozumi, Y. (Shionogi & Co. Ltd.); Process for producing imidazole derivs.. EP 0949249; US 6057448; WO 9829395 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(XII) | 35846 | [5-[(3,5-dichlorophenyl)sulfanyl]-4-isopropyl-1-(4-pyridinylmethyl)-1H-imidazol-2-yl]methanol | C19H19Cl2N3OS | 详情 | 详情 | |
(XVII) | 63300 | 3,5-dichlorobenzenesulfenyl chloride | C6H3Cl3S | 详情 | 详情 | |
(XVIII) | 63301 | [4-isopropyl-1-(4-pyridinylmethyl)-1H-imidazol-2-yl]methanol | C13H17N3O | 详情 | 详情 | |
(XX) | 63303 | [4-isopropyl-1-(4-pyridinylmethyl)-1H-imidazol-2-yl]methyl acetate | C15H19N3O2 | 详情 | 详情 | |
(XXI) | 63304 | [5-[(3,5-dichlorophenyl)sulfanyl]-4-isopropyl-1-(4-pyridinylmethyl)-1H-imidazol-2-yl]methyl acetate | C21H21Cl2N3O2S | 详情 | 详情 |
Extended Information